GlaxoSmithKline fined for illegally marketing dangerous drugs
Pharmaceutical giant GlaxoSmithKline was recently slapped with a $3 billion fine for illegally marketing a variety of drugs for unapproved, off-label uses. Authorities brought criminal and civil fines against GSK
